{"id":"https://openalex.org/W7225205508","doi":"https://doi.org/10.1186/s12913-026-16025-5","title":"Cost-effectiveness analysis of cadonilimab combined with chemotherapy as first-line treatment for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma","display_name":"Cost-effectiveness analysis of cadonilimab combined with chemotherapy as first-line treatment for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma","publication_year":2026,"publication_date":"2026-11-03","ids":{"openalex":"https://openalex.org/W7225205508","doi":"https://doi.org/10.1186/s12913-026-16025-5"},"language":"en","primary_location":{"id":"doi:10.1186/s12913-026-16025-5","doi":"https://doi.org/10.1186/s12913-026-16025-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12913-026-16025-5","pdf_url":null,"source":{"id":"https://openalex.org/S12898181","display_name":"BMC Health Services Research","issn_l":"1472-6963","issn":["1472-6963"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-b","doyens","fnege-4","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Health Services Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1186/s12913-026-16025-5","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160480588","display_name":"Lian Tang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lian Tang","raw_affiliation_strings":["Department of Pharmacy, Nantong First People\u2019s Hospital, Southeast University, No. 666, Shengli Road, Nantong, Jiangsu Province, 226001, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Nantong First People\u2019s Hospital, Southeast University, No. 666, Shengli Road, Nantong, Jiangsu Province, 226001, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057751171","display_name":"LongXun Zhu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"LongXun Zhu","raw_affiliation_strings":["Department of Pharmacy, Nantong First People\u2019s Hospital, Southeast University, No. 666, Shengli Road, Nantong, Jiangsu Province, 226001, China","Nantong Key Laboratory of Innovative Research on Rheumatology and Immunology, Nantong, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Nantong First People\u2019s Hospital, Southeast University, No. 666, Shengli Road, Nantong, Jiangsu Province, 226001, China","institution_ids":[]},{"raw_affiliation_string":"Nantong Key Laboratory of Innovative Research on Rheumatology and Immunology, Nantong, Jiangsu Province, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120991525","display_name":"Shaoqing Zhan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ShaoQing Zhan","raw_affiliation_strings":["Department of Pharmacy, Nantong First People\u2019s Hospital, Southeast University, No. 666, Shengli Road, Nantong, Jiangsu Province, 226001, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Nantong First People\u2019s Hospital, Southeast University, No. 666, Shengli Road, Nantong, Jiangsu Province, 226001, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100454357","display_name":"Yong Chen","orcid":"https://orcid.org/0000-0001-5090-417X","observed_orcids":["https://orcid.org/0000-0001-5090-417X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Yong Chen","raw_affiliation_strings":["Department of Pharmacy, Nantong First People\u2019s Hospital, Southeast University, No. 666, Shengli Road, Nantong, Jiangsu Province, 226001, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Nantong First People\u2019s Hospital, Southeast University, No. 666, Shengli Road, Nantong, Jiangsu Province, 226001, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031628702","display_name":"Pan-Feng Feng","orcid":"https://orcid.org/0000-0001-7817-7971","observed_orcids":["https://orcid.org/0000-0001-7817-7971"]},"institutions":[{"id":"https://openalex.org/I199305430","display_name":"Nantong University","ror":"https://ror.org/02afcvw97","country_code":"CN","type":"education","lineage":["https://openalex.org/I199305430"]},{"id":"https://openalex.org/I4401726949","display_name":"Second Affiliated Hospital of Nantong University","ror":"https://ror.org/05pdn2z45","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4401726949"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Pan-Feng Feng","raw_affiliation_strings":["Department of Pharmacy, Affiliated Nantong Clinical College of Nantong University, Nantong First People\u2019s Hospital, Nantong, Jiangsu Province, China","Department of Pharmacy, Nantong First People\u2019s Hospital, Southeast University, No. 666, Shengli Road, Nantong, Jiangsu Province, 226001, China","Nantong Key Laboratory of Innovative Research on Rheumatology and Immunology, Nantong, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Affiliated Nantong Clinical College of Nantong University, Nantong First People\u2019s Hospital, Nantong, Jiangsu Province, China","institution_ids":["https://openalex.org/I199305430","https://openalex.org/I4401726949"]},{"raw_affiliation_string":"Department of Pharmacy, Nantong First People\u2019s Hospital, Southeast University, No. 666, Shengli Road, Nantong, Jiangsu Province, 226001, China","institution_ids":[]},{"raw_affiliation_string":"Nantong Key Laboratory of Innovative Research on Rheumatology and Immunology, Nantong, Jiangsu Province, China","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5031628702","https://openalex.org/A5100454357"],"corresponding_institution_ids":["https://openalex.org/I199305430","https://openalex.org/I4401726949"],"apc_list":{"value":3290,"currency":"USD","value_usd":3290},"apc_paid":{"value":3290,"currency":"USD","value_usd":3290},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.89085255,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0142000000923872,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cadonilimab","display_name":"cadonilimab","score":0.9950000047683716},{"id":"https://openalex.org/keywords/xelox","display_name":"XELOX","score":0.8119999766349792},{"id":"https://openalex.org/keywords/her2-negative-gastric-cancer","display_name":"HER2-negative gastric cancer","score":0.7720000147819519},{"id":"https://openalex.org/keywords/gastroesophageal-junction-adenocarcinoma","display_name":"gastroesophageal junction adenocarcinoma","score":0.9869999885559082},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7860000133514404},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9129999876022339},{"id":"https://openalex.org/keywords/incremental-cost-effectiveness-ratio","display_name":"incremental cost-effectiveness ratio","score":0.7329999804496765},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8790000081062317},{"id":"https://openalex.org/keywords/partitioned-survival-model","display_name":"partitioned survival model","score":0.7049999833106995},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.7699999809265137},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.9670000076293945},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.4449999928474426}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9261000156402588},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.7889000177383423},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.7483000159263611},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.695900022983551},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6437000036239624},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6121000051498413},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.45559999346733093},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4269999861717224},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.38609999418258667},{"id":"https://openalex.org/C21200559","wikidata":"https://www.wikidata.org/wiki/Q7451068","display_name":"Sensitivity (control systems)","level":2,"score":0.37779998779296875},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.337799996137619},{"id":"https://openalex.org/C2909600360","wikidata":"https://www.wikidata.org/wiki/Q1029907","display_name":"Gastroesophageal Junction","level":4,"score":0.31700000166893005},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.31290000677108765},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3005000054836273},{"id":"https://openalex.org/C151032500","wikidata":"https://www.wikidata.org/wiki/Q5194182","display_name":"Cumulative dose","level":2,"score":0.2897999882698059},{"id":"https://openalex.org/C2778260052","wikidata":"https://www.wikidata.org/wiki/Q117636","display_name":"FOLFOX","level":5,"score":0.28850001096725464},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2831000089645386},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.27889999747276306},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.26339998841285706},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.25920000672340393},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.2551000118255615}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1186/s12913-026-16025-5","doi":"https://doi.org/10.1186/s12913-026-16025-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12913-026-16025-5","pdf_url":null,"source":{"id":"https://openalex.org/S12898181","display_name":"BMC Health Services Research","issn_l":"1472-6963","issn":["1472-6963"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-b","doyens","fnege-4","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Health Services Research","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1186/s12913-026-16025-5","doi":"https://doi.org/10.1186/s12913-026-16025-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12913-026-16025-5","pdf_url":null,"source":{"id":"https://openalex.org/S12898181","display_name":"BMC Health Services Research","issn_l":"1472-6963","issn":["1472-6963"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-b","doyens","fnege-4","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Health Services Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4413312631","https://openalex.org/W7135072124","https://openalex.org/W4412508546","https://openalex.org/W4410331588","https://openalex.org/W4412732727","https://openalex.org/W4414829010","https://openalex.org/W4415165091","https://openalex.org/W7167702858","https://openalex.org/W4386863751","https://openalex.org/W4410607509"],"abstract_inverted_index":{"Abstract":[0],"Objective":[1],"To":[2],"assess":[3],"the":[4,104,119,149],"cost-effectiveness":[5,62],"of":[6,100,142],"cadonilimab":[7,83,153],"plus":[8,12],"XELOX":[9],"versus":[10],"placebo":[11],"oxaliplatin":[13],"and":[14,56,132],"capecitabine":[15],"(XELOX)":[16],"as":[17],"first-line":[18],"therapy":[19],"for":[20,159],"HER2-negative":[21,160],"advanced":[22,161],"gastric/gastroesophageal":[23],"junction":[24],"(G/GEJ)":[25],"adenocarcinoma.":[26,163],"Methods":[27],"A":[28],"partitioned":[29],"survival":[30,36],"model":[31,120],"with":[32,67,154],"three":[33],"states":[34],"(progression-free":[35],"[PFS],":[37],"progressed":[38],"disease":[39],"[PD],":[40],"death)":[41],"was":[42,121],"developed":[43],"over":[44],"a":[45],"10-year":[46],"horizon":[47],"(21-day":[48],"cycles,":[49],"5%":[50],"discount":[51],"rate).":[52],"Outcomes":[53],"included":[54],"costs":[55,93],"quality-adjusted":[57],"life":[58],"years":[59],"(QALYs).":[60],"Incremental":[61],"ratios":[63],"(ICERs)":[64],"were":[65],"calculated,":[66],"sensitivity":[68,115,137],"analyses":[69],"(one-way,":[70],"probabilistic":[71,136],"[PSA])":[72],"to":[73,84,97,124],"evaluate":[74],"robustness.":[75],"Results":[76],"The":[77],"base-case":[78],"analysis":[79,116,138],"demonstrated":[80],"that":[81,118],"adding":[82],"chemotherapy":[85,155],"improved":[86],"outcomes":[87],"by":[88,94],"0.25":[89],"QALYs":[90],"but":[91],"increased":[92],"\u00a5217,521,":[95],"leading":[96],"an":[98],"ICER":[99],"\u00a5870,084":[101],"per":[102,112],"QALY\u2014surpassing":[103],"acceptable":[105],"WTP":[106,151],"threshold":[107],"(3\u00d7":[108],"China\u2019s":[109],"2024":[110],"GDP":[111],"capita).":[113],"One-way":[114],"revealed":[117],"most":[122],"sensitive":[123],"changes":[125],"in":[126],"PD/PFS":[127],"health":[128],"utilities,":[129],"drug":[130],"cost,":[131],"body":[133],"weight.":[134],"Notably,":[135],"suggested":[139],"0%":[140],"probability":[141],"this":[143],"strategy":[144],"being":[145],"cost-effective.":[146],"Conclusion":[147],"At":[148],"current":[150],"threshold,":[152],"is":[156],"not":[157],"cost-effective":[158],"G/GEJ":[162],"Clinical":[164],"trial":[165],"number":[166],"Not":[167],"applicable.":[168]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-11-04T00:00:00"}